EGFR and its ligand, epidermal growth factor (EGF), play critical roles in the progression of ovarian cancer through their effects on cellular proliferation, apoptosis, angiogenesis, and metastasis [4-6]. This evidence concerns the gene EGF and ovarian carcinoma.